Oramed pharmaceuticals inc. (ORMP)
CashFlow / TTM
Feb'20Nov'19Aug'19May'19Feb'19Nov'18Aug'18May'18Feb'18Nov'17Aug'17May'17Feb'17Nov'16Aug'16May'16Feb'16Nov'15Aug'15May'15Feb'15Nov'14Aug'14May'14Feb'14Nov'13Aug'13May'13Feb'13Nov'12Aug'12May'12Feb'12Nov'11Aug'11May'11Feb'11Nov'10
CASH FLOWS FROM OPERATING ACTIVITIES:
NET LOSS FOR THE PERIOD

-

-12,596

-

-

-

-14,498

-12,727

-12,497

-10,108

-10,375

-10,480

-24,952

-12,575

-11,210

-10,964

4,088

-7,907

-7,726

-7,232

-14,879

-6,990

-6,468

-5,696

11,739

4,177

4,066

4,232

-4,770

-4,064

-3,824

-3,344

-2,787

-1,779

-1,436

-1,561

0

0

0

Adjustments required to reconcile net loss to net cash used in operating activities:
Depreciation

-

-

8

6

7

7

6

5

6

5

5

5

4

4

4

0

0

0

-

-

-

-

-

-

-

-

5

0

0

0

-

22

24

26

28

0

0

0

Depreciation

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

-

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Amortization of debt discount

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

-

0

0

0

0

0

0

0

Exchange differences and interest on deposits and held to maturity bonds

117

159

183

187

167

23

-22

-281

-287

-165

-124

152

119

241

163

105

85

45

20

51

32

16

29

4

39

21

-19

-72

-64

-102

-62

24

8

51

30

0

0

0

Changes in fair value of investments

-531

-800

-437

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Stock-based compensation

955

849

808

1,038

1,113

1,262

1,547

2,135

1,937

1,941

1,575

686

643

472

634

908

1,268

1,367

1,347

1,457

1,699

1,564

1,468

1,131

610

704

719

744

629

437

271

246

276

385

529

0

0

0

Shares issued for services

41

36

55

93

100

111

99

81

83

79

72

71

85

93

101

105

115

92

93

107

64

64

102

214

308

308

244

109

83

108

108

91

132

138

227

0

0

0

Gain on sale of investment

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

80

60

65

68

50

0

0

0

-

-

-

-

-

-

-

-

Exchange of warrants

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

-

Shares to be issued for services rendered

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

-

Common stock to be issued for services

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

Gain on sale of investment

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

1,033

1,033

0

0

0

Impairment of investment

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

-

0

0

0

0

0

0

0

Imputed interest

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

0

1

2

3

0

0

0

Impairment of available for sale securities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

140

184

184

240

240

197

197

0

0

0

Exchange of warrants

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

-

0

0

0

-

-

-

-

Changes in fair value of warrant liabilities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

-

-

-

-

-

-

-

-

Changes in operating assets and liabilities:
Accounts payable, accrued expenses and related parties

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Changes in fair value of warrant liabilities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

-

Prepaid expenses and other current assets

-387

-118

468

185

726

564

415

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

-

-

-23

-25

36

0

0

0

Prepaid expenses and other current assets

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Prepaid expenses and other current assets

-

-

-

-

-

-

-

-

-

-

-

-

0

0

-

-

-

-

-345

-232

-189

-31

319

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Accounts payable, accrued expenses and related parties

18

-1,142

501

-675

132

358

-612

601

-215

391

1,257

1,899

1,614

1,480

470

-77

265

-23

16

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Contract liabilities

-

0

-

-

-

0

-

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Deferred revenues

-

-

-

-

-

-

-

-

-

-

1,520

12,309

12,763

17,632

14,266

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Restricted cash

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

-

0

0

-0

-0

0

0

0

Accounts payable and accrued expenses

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

90

-112

-89

203

-3

16

41

-17

0

0

0

Liability for employee rights upon retirement

0

0

-

-

-

-

2

1

2

5

4

5

4

2

3

3

4

3

2

1

0

0

1

-3

-2

-3

1

3

1

3

-2

23

23

22

22

0

0

0

Other liabilities

-

-

-42

-42

-98

-142

-130

-132

-77

-78

53

462

481

501

390

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Provision for uncertain tax position

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

90

90

-36

-36

-36

-36

0

0

0

Total net cash used in operating activities

-13,550

-11,805

-12,940

-14,320

-14,468

-16,060

-14,657

-12,057

-10,608

-10,057

-5,831

3,020

3,151

8,400

4,655

-3,177

-1,866

-5,794

-4,946

-4,719

-4,841

-4,719

-4,068

-3,546

-3,560

-3,351

-3,396

-3,456

-3,291

-2,609

-2,301

-2,381

-2,086

-1,691

-1,705

0

0

0

CASH FLOWS FROM INVESTING ACTIVITIES:
Purchase of short-term deposits

0

0

-

-

-

-

7,101

5,851

6,408

4,596

3,557

2,556

2,625

7,410

7,010

0

0

0

-

-

-

-

-

-

0

0

-

2,292

3,299

475

475

509

-937

1,700

1,700

0

0

0

Purchase of long-term deposits

-

-

-

-

-

-

15,040

11,770

13,770

17,770

17,230

22,400

23,774

25,274

22,274

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Purchase of held to maturity securities

-

-

1,357

2,297

1,947

1,947

4,429

3,844

4,658

5,692

3,869

2,904

2,090

2,831

1,775

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Purchase of short-term and long-term deposits

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Proceeds from sale of investments

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

0

0

0

-

0

0

0

Proceeds from sale of short-term deposits

44,560

40,211

38,611

16,921

15,151

17,861

17,316

26,116

27,423

27,686

26,551

20,441

21,884

14,060

14,160

15,870

18,571

18,821

19,701

20,299

41,053

40,739

42,539

35,540

6,290

4,699

1,054

454

1,800

2,254

1,800

1,800

0

-100

0

0

0

0

Proceeds from maturity of held to maturity securities

4,150

4,075

3,250

2,850

2,250

1,800

2,257

1,919

2,724

2,974

2,417

2,405

1,200

1,200

900

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Proceeds from sale of marketable securities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Funds in respect of employee rights upon retirement

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

2

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Purchase of property and equipment

10

10

15

0

0

0

-

-

-

-

-

-

-

-

9

8

1

1

1

4

7

11

14

13

15

11

6

4

-0

2

2

2

2

2

2

0

0

0

Funds in respect of employee rights upon retirement

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

-5

-5

0

-2

-0

0

5

6

4

3

0

0

0

Lease deposits, net

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

-

0

-2

-2

-2

0

0

0

Total net cash provided by investing activities

13,714

11,089

11,259

-1,931

-2,208

1,137

-7,004

6,563

5,300

2,592

4,302

-5,022

-5,417

-20,264

-16,010

-14,185

-12,777

-3,970

-3,312

1,264

-2,271

-11,450

-13,088

-16,104

-16,112

-5,185

-4,569

-1,620

-1,386

1,774

1,769

1,732

1,380

-1,354

-1,703

0

0

0

CASH FLOWS FROM FINANCING ACTIVITIES:
Proceeds from issuance of common stock, net of issuance costs

0

0

-

-

-

-

-

0

0

4,255

-

0

0

0

-

-

-

-

9,713

4,833

4,833

19,720

14,887

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Proceeds from exercise of warrants and options

-

-

-

-

-

-

997

2,238

2,238

2,171

1,561

431

483

1,605

1,449

0

0

0

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Proceeds from shares to be issued for exercise of warrants

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

4,939

4,939

4,947

3,489

0

588

3,394

3,694

0

0

0

Proceeds from exercise of warrants and options

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

Proceeds from exercise of options

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Receipts on account of shares issuances

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

-

0

0

0

0

0

0

0

Proceeds from convertible notes

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

-

0

0

0

0

0

0

0

Proceeds from short term note payable

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

-

0

0

0

0

0

0

0

Payments of short term note payable

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

-

0

0

0

0

0

0

0

Shareholder advances

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

-

0

0

0

0

0

0

0

Total net cash provided by financing activities

0

0

-

-

-

-

22,654

7,427

7,144

6,426

1,586

431

483

12,199

12,043

16,812

16,760

5,052

9,721

4,843

4,986

21,473

16,640

21,011

20,868

4,365

5,824

4,939

4,939

4,947

3,489

0

588

3,394

3,694

0

0

0

EFFECT OF EXCHANGE RATE CHANGES ON CASH

0

0

-

-

34

32

34

7

7

7

5

2

5

6

6

5

11

5

-12

-16

-25

-19

6

9

18

10

-18

-56

-45

-75

-39

0

0

0

-

-

-

-

INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS

2,505

-690

-1,667

273

134

2,603

1,027

1,940

1,843

-1,032

62

-1,569

-1,778

341

694

-545

2,128

-4,707

1,451

1,372

-2,151

5,285

-510

1,369

1,212

-4,160

-2,159

0

0

0

-

-

-

-

313

0

0

0

SUPPLEMENTARY DISCLOSURE ON CASH FLOWS -
Interest received

816

882

929

860

830

852

826

861

1,002

910

833

633

462

282

256

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Shares issued for offering costs

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

-

76

76

76

76

0

0

0

Contribution to paid in capital

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

-

0

0

0

-

0

0

0

Discount on convertible note related to beneficial conversion feature

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

-

0

0

0

-

0

0

0

Exchange of warrants

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

-

-

-

-

-

-

-

-

Shares issued for marketable securities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

-

-

-

-

-

-

-

-

Shares and warrants issued for marketable securities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

-